PMID: 8942462Dec 1, 1996Paper

Fluoxetine augmentation of clozapine treatment in patients with schizophrenia

The American Journal of Psychiatry
R W BuchananA Breier

Abstract

The authors examined the efficacy of fluoxetine augmentation of clozapine treatment response in schizophrenic outpatients who, despite adequate treatment with clozapine, continued to exhibit persistent positive or negative symptoms. Thirty-three patients completed on 8-week, double-blind, parallel-groups comparison of adjunctive fluoxetine and placebo. There were no significant differences in positive, negative, depressive, or obsessive-compulsive symptoms between patients given adjunctive fluoxetine or placebo. These results suggest that fluoxetine is not effective in augmenting clozapine treatment response.

Citations

Feb 26, 2014·European Journal of Medicinal Chemistry·Yogita Bansal, Om Silakari
Jan 1, 1998·International Journal of Psychiatry in Clinical Practice·D ZullinoP Baumann
Oct 7, 2014·Expert Opinion on Pharmacotherapy·Maria Rosaria A MuscatelloRocco Zoccali
Dec 3, 2015·Psychopharmacology·Christoffer Polcwiartek, Jimmi Nielsen
Sep 22, 2005·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Peter FalkaiUNKNOWN WFSBP Task Force on Treatment Guidelines for Schizophrenia
Mar 3, 2006·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Peter FalkaiUNKNOWN WFSBP Task Force on Treatment Guidelines for Schizophrenia
Sep 13, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Stefano PorcelliAlessandro Serretti
Aug 28, 2007·The Psychiatric Clinics of North America·Helio Elkis
Aug 26, 2006·Schizophrenia Research·Brendan P MurphyPatrick D McGorry
May 21, 2015·The International Journal of Neuropsychopharmacology·Viacheslav TerevnikovJan-Henry Stenberg
May 14, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·A MurruE Vieta
Jul 10, 2013·European Journal of Pharmacology·Andrea de BartolomeisCarmine Tomasetti
May 6, 2016·Expert Opinion on Pharmacotherapy·Massimiliano BuoliA Carlo Altamura
Jul 13, 2001·Journal of Psychopharmacology·S G Siris
Oct 31, 2002·Human Psychopharmacology·Hitoshi TakahashiTetsuo Shimizu
Sep 12, 2001·The Australian and New Zealand Journal of Psychiatry·E F Cheung
Jul 31, 2008·Drugs & Aging·John W Kasckow, Sidney Zisook
Sep 28, 2005·CNS Drugs·Gary RemingtonChekkera Shammi
Mar 7, 2006·Clinical Neuropharmacology·Constantin TranulisDavid Gourion
Sep 3, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Lisa WilliamsClare Brabbins
Sep 1, 2019·International Journal of Psychiatry in Medicine·Paul A Zarkowski
Dec 17, 2004·International Clinical Psychopharmacology·M C Jockers-ScherüblP Schlattmann
Feb 9, 2000·The Journal of Nervous and Mental Disease·C ArangoR W Buchanan
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Adib EssaliJohn Rathbone
Sep 21, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·Vassilis P KontaxakisDimitris K Roukas
Dec 1, 2003·European Psychiatry : the Journal of the Association of European Psychiatrists·Patrice Boyer
Mar 15, 2015·Current Opinion in Psychiatry·Seiya MiyamotoW Wolfgang Fleischhacker
Jan 25, 2011·CNS Drugs·John KasckowSidney Zisook
May 8, 2018·The Australian and New Zealand Journal of Psychiatry·Dan J SiskindSteve Kisely
Aug 10, 1999·Journal of Clinical Psychopharmacology·M L LuW H Chang
Sep 14, 2004·CNS Spectrums·Alexander L Miller
Oct 19, 2001·CNS Drug Reviews·H Silver
Aug 26, 2004·CNS Spectrums·D C GoffA E Evins
May 15, 2019·Journal of Medicinal Chemistry·Junting ZhouHaopeng Sun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.